Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Glucobay OD approved in Japan for diabetes

Jan. 20, 2010

Takeda's orally disintegrating Actos tablets approved in Japan for type 2 diabetes

Jan. 19, 2010

Novel PPAR agonists claimed by sanofi-aventis as antidiabetic agents

Jan. 19, 2010

European orphan drug status recommended for Protalix's taliglucerase alfa for GD

Jan. 19, 2010

Alogliptin equally effective in younger and elderly patients with type 2 diabetes

Jan. 19, 2010

Spherix completes enrollment into phase III trial of D-tagatose in type 2 diabetes

Jan. 19, 2010

Transdermal patch effectively delivers teriparatide in postmenopausal women with osteoporosis

Jan. 18, 2010

Premier Research begins phase II trial of Vantia's VA-111913 for menstrual cramps

Jan. 18, 2010

Novel sulfonylureas in development for diabetes therapy at Concert Pharmaceuticals

Jan. 15, 2010

Genfit reports results from phase I safety study of GFT-505/simvastatin combination

Jan. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...